Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
UNM heads into its November 3 earnings date with the stock up 4% on the week yet sitting 4% below its one-month peak, a gap that captures the tension between a recovering share price and a Street that is quietly nudging its targets lower.
The most current analyst action came this morning: Barclays trimmed its price target by a dollar to $109 while holding an Overweight rating. That single-dollar cut is token, but it lands in a broader context where targets have been drifting down since late July. JP Morgan cut from $101 to $98 in early August. Keefe, Bruyette and Woods dropped from $110 to $108 after the last earnings print. The consensus mean now sits at $101.85, roughly 11% above the current price of $91.83. The bulls, led by Jefferies at $123 and Evercore ISI at $111, see structural tailwinds: higher interest rates, demographic demand for disability and group benefits products, and a franchise generating over 20% return on equity with strong free cash flow conversion. The bears counter with rising group disability benefit ratios and long-term care incidence risk, concerns that have pushed EPS estimates lower in recent months. The 90-day forward earnings momentum factor ranks in only the 17th percentile, confirming that near-term estimate revisions have been soft even as the longer-horizon EPS growth picture scores in the 81st percentile.
Positioning tells a story of minimal short-side pressure. Short interest runs at just under 2.5% of free float, around 4.16 million shares, down slightly on the week and broadly flat over the past month after a 25% jump in the position from early September levels. That jump is worth noting: short interest climbed from roughly 3.3 million shares in early September to over 4.3 million by mid-month, before easing back. Even so, 2.5% of float is a low absolute level, and the borrow market reflects that completely. The cost to borrow is under 0.5%, well within normal territory. Availability is effectively unlimited, meaning there is no supply constraint for anyone wanting to establish or expand a short position. The ORTEX short score sits at 32.9, a low reading that places the stock in the 61st percentile by short score rank but signals no particular squeeze dynamic. This is not a battleground stock.
Options positioning reinforces the broadly benign picture. The put/call ratio is running at 0.06, fractionally above its 20-day average of 0.058 and less than one standard deviation from the mean. The 52-week high on the PCR was 0.77, a level that looks almost incomprehensibly distant from where the ratio trades today. Call open interest overwhelmingly dominates the options chain, which is consistent with an institutional-owned, dividend-paying insurer where hedging demand is structural but not elevated. There is no defensive spike in the data ahead of November 3.
The ownership picture is notable for its stability. BlackRock reported 11.4% of shares as of the end of September, up from 9.2% at its prior filing, a meaningful increase from the largest holder. Norges Bank held 8.4% and FMR (Fidelity) 4.7%, though both as reported at June 30. Insider activity in the window ending September 10 was net negative: a director sold 4,300 shares at $94.02, the General Counsel sold 4,000 shares at $94.44, and the Chief Accounting Officer sold a further 2,188 shares at $94.32. None of these trades were disclosed as being under a pre-arranged 10b5-1 plan, and the 90-day net insider position runs to roughly negative 10,500 shares worth close to $1 million. The stock was trading above $94 at the time of those sales and has since pulled back to $91.83, meaning those sellers got out at better levels than today's close.
One alt-data reading from the ORTEX coverage deserves a brief mention: Wikipedia page views for Unum are running at a z-score of 2.6 against the company's own 90-day history, as of late September. That is an attention signal, not a revenue indicator, but the spike is notable for a stock that ordinarily attracts little retail traffic.
The next focal point is the November 3 earnings event. The past three prints have produced day-one moves of minus 3.2%, minus 1.3%, and plus 0.8%, with the five-day drift generally recovering most or all of the initial drop. What to watch is whether the group disability benefit ratio and long-term care incidence trends the bears have flagged since the July print show any improvement, or whether the sequential pressure that drove the post-July target cuts continues into the third quarter.
See the live data behind this article on ORTEX.
Open UNM on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
